牛叉诊股

[{"date":"2026.07.06","stock":"2.02","trade":"0.48","ind":"-0.06"},{"date":"2026.07.03","stock":"8.36","trade":"1.67","ind":"0.37"},{"date":"2026.07.02","stock":"-2.93","trade":"1.31","ind":"-2.03"},{"date":"2026.07.01","stock":"3.58","trade":"4.04","ind":"0.44"},{"date":"2026.06.30","stock":"0.14","trade":"-2.41","ind":"0.50"},{"date":"2026.06.29","stock":"10.02","trade":"3.70","ind":"1.16"},{"date":"2026.06.26","stock":"-5.18","trade":"-3.12","ind":"-2.26"},{"date":"2026.06.25","stock":"-1.70","trade":"-1.85","ind":"0.23"},{"date":"2026.06.24","stock":"-1.94","trade":"-2.01","ind":"0.11"},{"date":"2026.06.23","stock":"0.42","trade":"2.18","ind":"-1.37"},{"date":"2026.06.22","stock":"-7.24","trade":"-0.45","ind":"1.78"},{"date":"2026.06.18","stock":"-1.78","trade":"-0.26","ind":"-0.43"},{"date":"2026.06.17","stock":"-2.72","trade":"-1.01","ind":"0.40"},{"date":"2026.06.16","stock":"2.79","trade":"-0.94","ind":"-0.11"},{"date":"2026.06.15","stock":"-0.25","trade":"0.19","ind":"1.61"},{"date":"2026.06.12","stock":"3.81","trade":"1.37","ind":"1.12"},{"date":"2026.06.11","stock":"-2.19","trade":"-1.40","ind":"-0.16"},{"date":"2026.06.10","stock":"-4.07","trade":"-0.21","ind":"-0.42"},{"date":"2026.06.09","stock":"-0.12","trade":"-0.20","ind":"1.28"},{"date":"2026.06.08","stock":"-6.67","trade":"-2.15","ind":"-1.70"},{"date":"2026.06.05","stock":"0.00","trade":"0.78","ind":"-0.74"}]

太龙药业,上证指数,中药指数

压力支撑

该股压力位为7.98元，支撑位为7.71元。

[{"text":"\u538b\u529b\u4f4d","value":"7.98","date":1783267200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.71","date":1783267200,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.4资金面打败了59%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：07月06日 20:31

机构今日流向(万元)	607.62	机构5日流向(万元)	1542.52
机构10日流向(万元)	-549.74	机构20日流向(万元)	-5782.62

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少605.92万股，其中基金净增仓1家，主力净减仓15家，暂未发现中长期投资价值。

截止2025-12-31，共27家主力机构（基金24家，QFII1家，一般法人2家），持仓量总计14394.4万股，占流通A股25.08%
其中，基金持仓与2025-06-30相比：
增仓：7家，增持 153.11万股
减仓：6家，减持 139.93万股
新出现在主力名单中：11家，持有437.79万股
从主力名单中消失：26家，原持有1056.89万股

消息面诊股

诊断结果：5.5消息面打败了50%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向	公司出售资产	2026-06-06
一般消息	股东大会	年度股东大会	2026-05-01
一般消息	分红转增	不分配不转增	2026-04-15
一般消息	重大事项	关联交易	2026-04-15
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
利好	股票增发	董事会通过	2025-12-09
一般消息	资产重组	公司股权转让	2025-12-09
一般消息	重大事项	关联交易	2025-12-09
一般消息	重大事项	关联交易	2025-11-12
利好	分红转增	10派0.14元(含税)	2025-10-30
一般消息	重大事项	公司股东股份冻结	2025-10-17
一般消息	重大事项	关联交易	2025-09-27
一般消息	重大事项	关联交易	2025-09-20
一般消息	分红转增	不分配不转增	2025-08-27
一般消息	高管变动	取消监事会	2025-08-15

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：7.7行业面打败了97%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.07.06","price":"-0.06","value":"0.48"},{"date":"2026.07.03","price":"0.37","value":"1.67"},{"date":"2026.07.02","price":"-2.03","value":"1.31"},{"date":"2026.07.01","price":"0.44","value":"4.04"},{"date":"2026.06.30","price":"0.50","value":"-2.41"},{"date":"2026.06.29","price":"1.16","value":"3.70"},{"date":"2026.06.26","price":"-2.26","value":"-3.12"},{"date":"2026.06.25","price":"0.23","value":"-1.85"},{"date":"2026.06.24","price":"0.11","value":"-2.01"},{"date":"2026.06.23","price":"-1.37","value":"2.18"},{"date":"2026.06.22","price":"1.78","value":"-0.45"},{"date":"2026.06.18","price":"-0.43","value":"-0.26"},{"date":"2026.06.17","price":"0.40","value":"-1.01"},{"date":"2026.06.16","price":"-0.11","value":"-0.94"},{"date":"2026.06.15","price":"1.61","value":"0.19"},{"date":"2026.06.12","price":"1.12","value":"1.37"},{"date":"2026.06.11","price":"-0.16","value":"-1.40"},{"date":"2026.06.10","price":"-0.42","value":"-0.21"},{"date":"2026.06.09","price":"1.28","value":"-0.20"},{"date":"2026.06.08","price":"-1.70","value":"-2.15"},{"date":"2026.06.05","price":"-0.74","value":"0.78"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	众生药业	32.56%	16.66%	6.9分
2	维康药业	19.76%	1.14%	5.1分
3	特一药业	14.41%	8.30%	4.7分
4	华森制药	14.12%	-0.72%	4.6分
5	吉林敖东	10.55%	3.65%	5.7分
6	天目药业	9.15%	11.25%	5.0分
7	佐力药业	6.52%	3.90%	6.0分
8	康惠股份	6.41%	1.38%	4.9分
9	以岭药业	6.04%	1.67%	6.2分
10	九芝堂	5.51%	5.51%	6.2分
11	沃华医药	5.14%	12.37%	6.1分
12	太极集团	4.07%	9.73%	5.8分
13	亚宝药业	3.46%	5.72%	6.2分
14	步长制药	3.32%	2.24%	5.6分
15	桂林三金	3.29%	7.66%	5.7分
16	羚锐制药	3.15%	7.03%	6.2分
17	康恩贝	2.99%	3.51%	6.8分
18	健民集团	2.96%	9.51%	5.9分
19	奇正藏药	2.73%	6.92%	5.2分
20	白云山	2.71%	5.11%	5.6分
21	仁和药业	2.46%	6.50%	6.0分
22	达仁堂	2.27%	5.58%	5.9分
23	康缘药业	1.87%	4.93%	5.9分
24	天士力	1.69%	5.48%	6.0分
25	云南白药	0.96%	1.55%	5.3分
26	盘龙药业	0.57%	5.48%	4.8分
27	方盛制药	0.41%	4.40%	5.8分
28	华润三九	0.29%	4.43%	6.2分
29	千金药业	0.21%	4.30%	6.5分
30	红日药业	0.00%	6.40%	5.4分
31	葵花药业	-0.16%	8.05%	5.6分
32	汉森制药	-0.32%	7.72%	5.7分
33	ST百灵	-0.44%	3.63%	4.7分
34	*ST香雪	-0.72%	-2.04%	4.6分
35	精华制药	-0.75%	3.91%	5.3分
36	佛慈制药	-1.46%	3.76%	5.6分
37	陇神戎发	-1.55%	4.97%	5.2分
38	华神科技	-1.83%	4.74%	5.3分
39	广誉远	-2.13%	6.58%	5.2分
40	昆药集团	-2.65%	4.97%	5.4分
41	振东制药	-3.07%	5.21%	4.9分
42	同仁堂	-3.34%	2.86%	5.3分
43	马应龙	-3.54%	3.95%	5.4分
44	东阿阿胶	-4.15%	3.80%	6.0分
45	新光药业	-4.37%	5.13%	4.6分
46	恩威医药	-4.39%	3.96%	4.9分
47	益佰制药	-4.64%	7.87%	5.4分
48	华润江中	-5.07%	2.63%	6.1分
49	片仔癀	-5.38%	1.39%	5.5分
50	新天药业	-5.98%	5.36%	4.2分
51	-	-6.24%	1.35%	分
52	信邦制药	-6.42%	2.97%	5.2分
53	太龙药业	-7.24%	11.31%	6.3分
54	ST葫芦娃	-8.37%	11.90%	5.1分
55	益盛药业	-8.41%	1.94%	4.8分
56	ST金花	-8.52%	9.05%	5.5分
57	-	-9.92%	1.71%	分
58	ST万邦	-10.32%	10.70%	5.2分
59	上海凯宝	-10.39%	4.34%	4.7分
60	寿仙谷	-10.44%	8.31%	5.6分
61	济川药业	-11.16%	-5.40%	6.3分
62	ST嘉应	-12.50%	12.83%	5.2分
63	古汉医药	-13.18%	0.59%	4.9分
64	中恒集团	-13.72%	7.14%	5.0分
65	康美药业	-13.91%	5.69%	5.0分
66	粤万年青	-15.26%	-12.75%	4.3分
67	三力制药	-20.66%	5.08%	5.7分
68	珍宝岛	-31.86%	6.95%	5.2分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.9基本面打败了51%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（35分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 56/107 ， 60/107。

[{"date":"2026-03-31","value":"0.16","vol":"2.21"},{"date":"2025-12-31","value":"3.77","vol":"-2.33"},{"date":"2025-09-30","value":"1.60","vol":"4.80"},{"date":"2025-06-30","value":"1.22","vol":"4.03"},{"date":"2025-03-31","value":"0.10","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	0.16	3.77	1.60	1.22	0.10
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"26.22","vol":"55.05"},{"date":"2025-12-31","value":"28.00","vol":"52.85"},{"date":"2025-09-30","value":"24.29","vol":"53.29"},{"date":"2025-06-30","value":"24.69","vol":"53.82"},{"date":"2025-03-31","value":"26.81","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	26.22	28.00	24.29	24.69	26.81
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 15/107 ， 8/107。

[{"date":"2026-03-31","value":"8.34","vol":"-5.58"},{"date":"2025-12-31","value":"-9.46","vol":"-6.76"},{"date":"2025-09-30","value":"-11.47","vol":"-7.84"},{"date":"2025-06-30","value":"-17.77","vol":"-7.78"},{"date":"2025-03-31","value":"-35.23","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	8.34	-9.46	-11.47	-17.77	-35.23
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"69.95","vol":"1.06"},{"date":"2025-12-31","value":"18.74","vol":"-80.25"},{"date":"2025-09-30","value":"-12.36","vol":"-2.78"},{"date":"2025-06-30","value":"-27.32","vol":"2.25"},{"date":"2025-03-31","value":"-92.80","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	69.95	18.74	-12.36	-27.32	-92.80
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 40/107 ， 25/107。

[{"date":"2026-03-31","value":"0.10","vol":"0.12"},{"date":"2025-12-31","value":"0.49","vol":"0.47"},{"date":"2025-09-30","value":"0.33","vol":"0.35"},{"date":"2025-06-30","value":"0.22","vol":"0.24"},{"date":"2025-03-31","value":"0.09","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.10	0.49	0.33	0.22	0.09
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.63","vol":"0.59"},{"date":"2025-12-31","value":"3.51","vol":"2.34"},{"date":"2025-09-30","value":"2.12","vol":"1.72"},{"date":"2025-06-30","value":"1.36","vol":"1.17"},{"date":"2025-03-31","value":"0.65","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.63	3.51	2.12	1.36	0.65
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-56.44","vol":"5.83"},{"date":"2025-12-31","value":"23.85","vol":"30.77"},{"date":"2025-09-30","value":"5.35","vol":"10.53"},{"date":"2025-06-30","value":"-27.92","vol":"22.82"},{"date":"2025-03-31","value":"3.39","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-56.44	23.85	5.35	-27.92	3.39
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.29","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.18","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.29	-	0.18	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 29/107 ， 6/107。

[{"date":"2026-03-31","value":"1.26","vol":"2.97"},{"date":"2025-12-31","value":"1.14","vol":"2.94"},{"date":"2025-09-30","value":"1.16","vol":"3.09"},{"date":"2025-06-30","value":"1.29","vol":"2.94"},{"date":"2025-03-31","value":"1.13","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.26	1.14	1.16	1.29	1.13
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.93","vol":"2.23"},{"date":"2025-12-31","value":"0.89","vol":"2.15"},{"date":"2025-09-30","value":"0.84","vol":"2.24"},{"date":"2025-06-30","value":"0.91","vol":"2.15"},{"date":"2025-03-31","value":"0.86","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.93	0.89	0.84	0.91	0.86
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 5/107 ， 5/107。

[{"date":"2026-03-31","value":"54.72","vol":"31.94"},{"date":"2025-12-31","value":"54.34","vol":"32.43"},{"date":"2025-09-30","value":"55.88","vol":"31.59"},{"date":"2025-06-30","value":"53.76","vol":"32.45"},{"date":"2025-03-31","value":"54.26","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	54.72	54.34	55.88	53.76	54.26
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.25","vol":"0.66"},{"date":"2025-12-31","value":"1.23","vol":"0.67"},{"date":"2025-09-30","value":"1.31","vol":"0.76"},{"date":"2025-06-30","value":"1.20","vol":"0.75"},{"date":"2025-03-31","value":"1.23","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	1.25	1.23	1.31	1.20	1.23
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"-0.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.44","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.51","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.60","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[太龙药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]